Home
Search

Press Releases

Get the latest on BIO's announcements, positions and views on everything from healthcare to biofuels. 

Featured Press Releases
BIO Announces 2021 Start-up Stadium Winner:…
Annual competition takes place during BIO’s International Convention
Learn more
BIO Promotes Sarah Gallo to Vice President,…
The Biotechnology Innovation Organization (BIO) is pleased to announce today the promotion of Sarah Gallo to Vice President, Agriculture and Environment. In her new role, Sarah will lead the policy and market access strategies for BIO’s Agriculture…
Learn more
BIO Cheers Senate Passage of Growing Climate…
Dr. Michelle McMurry-Heath, president and CEO of the Biotechnology Innovation Organization (BIO), released the following statement after the Senate passed the Growing Climate Solutions Act: “This bill is at the heart of everything we fight…
Learn more
All Press Releases
  • Show All
Search
Results
BIO Takes on Health Equity in Clinical Trials
June 10, 2021
First-ever BIO Clinical Trial Diversity Summit will engage stakeholders to build a sustainable and equitable clinical development ecosystem
BIO Cheers Biden Announcement to Share 20 Million Doses of Vaccines with Developing Nations
May 18, 2021
"The White House’s decision to send Covid-19 vaccines to countries in need is an important step to ensuring people around the globe have access to lifesaving shots and ending this global pandemic. “As part of BIO’s recently-proposed Global “SHARE”…
BIO Extends Agreement with Avantor
May 10, 2021
Today, the Biotechnology Innovation Organization (BIO) announced an extension through June 2029 to its established agreement with Avantor. Through this agreement, members across North America have access to a broad…
Support of "TRIPS" Waiver Sets Dangerous Precedent
May 5, 2021
Dr. Michelle McMurry-Heath, president and CEO of the Biotechnology Innovation Organization (BIO), released the following statement in response to the White House's support of waiving critical intellectual property rights for COVID-19…
Global “SHARE” Program for COVID could provide global protection against pandemic and create American jobs
May 4, 2021
Dr. Michelle McMurry-Heath, president and CEO of the Biotechnology Innovation Organization (BIO), sent a letter to President Joe Biden yesterday suggesting the establishment of a COVID Global Strategy for Harnessing Access Reaching Everyone (SHARE)…
BIO DIGITAL 2021 TO FEATURE WHO’s WHO IN PUBLIC HEALTH
May 3, 2021
Former CNN anchor Brooke Baldwin welcomes an all-star lineup including Albert Bourla, Francis Collins, Jennifer Doudna, Anthony Fauci, Sanjay Gupta, Richard Haass, Janet Woodcock, and a host of industry leaders
BIO's Dr. Michelle McMurry-Heath Comments on Passage of Washington State's Clean Fuel Standard
April 26, 2021
BIO President and CEO Dr. Michelle McMurry-Heath issued the following statement following the passage of a clean fuel standard bill (HB 1091) in Washington state. "With the passage of HB 1091, Washington state is showing once again that climate…
H.R. 3 To Handicap Future Medical Innovation, Destroy Hope for Vulnerable Patients
April 23, 2021
Following the re-introduction of the H.R. 3 drug pricing legislation, Rich Masters -- Chief Public Affairs and Advocacy Officer of  the Biotechnology Innovation Organization (BIO) -- made the following remarks: "On behalf of BIO’s…
Proposed “TRIPS” Waiver Is the WRONG Way To Attack Global Access for Vaccines to Developing Countries
April 20, 2021
Dr. Michelle McMurry-Heath, president and CEO of the Biotechnology Innovation Organization (BIO), yesterday sent a letter to U.S. Trade Representative (USTR) Ambassador Katherine Tai sharing BIO perspectives regarding the proposed WTO “TRIPS waiver”…
BIO Welcomes Collaboration With New HHS, USTR Leaders
March 18, 2021
The Biotechnology Innovation Organization (BIO) welcomes the confirmations this week of Katherine Tai to the position of U.S. Trade Representative (USTR) and Xavier Becerra to lead the Department of Health and Human Services (HHS).  The United…
gooddaybio-cover-final
Daily News You Can’t Afford to Miss

Read it in under 3 minutes!

The Good Day BIO newsletter is the only daily newsletter at the intersection of biotech, politics, and policy. 

Sign Up Today